mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.03 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.12 |
0.04 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.04 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |